Reposted by Lauren Sweet
Efficacy and Safety of Bictegravir Plus Lenacapavir: 48-Week Outcomes in People With HIV-1 Who Are Virologically Suppressed on Complex Antiretroviral Regimens at Baseline
bit.ly/48uft50
bit.ly
Efficacy and Safety of Bictegravir Plus Lenacapavir: 48-Week Outcomes in People With HIV-1 Who Are Virologically Suppressed on Complex Antiretroviral Regimens at Baseline
People with HIV-1 who are virologically suppressed and taking complex antiretroviral regimens face several challenges in terms of high pill burden, challen
